Uncovering Hidden Value in Small Cap Stocks

This chapter explores BioRad's undervalued position in the biotech sector, emphasizing its substantial ownership in the thriving Sartorius. It addresses the company's challenges in Wall Street's perception while highlighting the positive outlook based on the CEO's dedication to long-term value.